DONALD YEE to Drugs, Investigational
This is a "connection" page, showing publications DONALD YEE has written about Drugs, Investigational.
Connection Strength
0.060
-
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia. N Engl J Med. 2026 Apr 09; 394(14):1388-1398.
Score: 0.060